Ace Therapeutics is a company that has been focusing on the field of ophthalmology and provides a large number of outsourcing services related to ocular biomarkers. Our scientists use reverse phase high resolution mass spectrometry (HPLC-MS) or direct infusion mass spectrometry (DI-MS) to help customers better screen ocular lipidomic biomarkers and advance research projects.
Lipidomics is an emerging and promising field that analyzes different lipid molecules in biological samples. It is considered a branch of metabolomics and is defined as the comprehensive analysis of metabolites in biological samples. Lipids play critical roles in many physiological pathways and can serve as biomarkers of disease or as therapeutic targets to treat disease. The main lipidomics strategies are shotgun lipidomics and liquid chromatography coupled to mass spectrometry. In ophthalmology, a growing number of studies have used lipidomics to analyze potential biomarkers such as lipid mediators that regulate ocular inflammatory responses and tissues (arachidonic acid, eicosapentaene, acid and docosahexaenoic acid, prostaglandins, leukotrienes and hydroxy fatty acids, etc.), lipid mediators in the tear film (cholesterol esters, wax esters, triacylglycerides, diacylglyceride, etc.). In this case, based on lipidomics research enables better understanding of ocular diseases and development of novel biomarkers for early detection and diagnosis, treatment, progression and prognosis.
Fig. 1. Figure 1. Representation and lipid composition of the human tear film. (Khanna RK, et al., 2022)
As an industry leader in the field of ophthalmology, Ace Therapeutics has successfully developed a technology platform based on lipid composition analysis. Ace Therapeutics' scientists use shotgun lipidomics and liquid chromatography coupled with mass spectrometry to detect lipid mediators related to ocular diseases, and conduct qualitative and quantitative research to help global customers with their projects.
At Ace Therapeutics, our scientists have decades of experience in lipidomics and ophthalmology research. They are committed to providing support for global customers' ocular biomarker discovery through lipidomics, and designing and developing personalized projects.
Ace Therapeutics' team has rich experience in bioinformatics analysis and provides one-stop services from sample pre-processing to data post-analysis.
Ace Therapeutics' goal is to provide the most professional service to our global customers. Our scientists are always ready to provide high-quality lipidomics-based ocular biomarker discovery and analysis solutions to global customers. If you have questions about the content of this service, please feel free to contact us. We look forward to hearing from you.
Reference